Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After Rituximab
Clinical trial NCT01119794 · TERMINATED
Trial details
- NCT number
- NCT01119794
- Sponsor
- Brown University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2015-07-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.